USPTO serial 75582113
NATCHEM
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PHILLIPS, DERRICK
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NATCHEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Slough, Berkshire, SL1 4EF, GB
VANCOUVER, BRITISH COLUMBIA, CA
VANCOUVER, BRITISH COLUMBIA, CA
CAMBRIDGE, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LAURA A CORUZZI
LAURA A CORUZZI PENNIE & EDMONDS LLP1155 AVE OF THE AMERICASNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, chemical preparations, microbial extracts, plant extracts, enzymes and catalysts, derived from living organisms, for use in the manufacture of pharmaceuticals, drugs, agrochemical, cosmeceutials, neutraceuticals, dyes and preservatives for use in the pharmaceutical, biotechnology, agrochemical, industrial enzymes, paper and pulp, textile, mining, oil and gas, petrochemical, engineering, diagnostics and food and beverages industries and for use in industrial processes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations and substances for use in all therapeutic areas namely, vitamins, hormones, nutrients, ointments and salves and for use in the treatment of neurological, central nervous system, rheumatic and bone, cancer, oncological, metabolic, cardiovascular, infectious diseases, immune, allergy, respiratory, opthalmological, dermatological, endocrine, hormonal, gastrointestinal, pain, wound, gynocological, hematological, hepatological, urological diseases and disorders | ACTIVE | — |
| 042 | Research and development services for the discovery of novel pharmaceuticals, drugs, agrochemicals, cosmeceuticals, neutraceuticals, dyes, preservatives, enzymes and catalysts; research and development services for others for chemical, biochemical, and biological products; research and development services for others for the improvement of existing products; research and development services for others for the development of assay systems; research and development services for others for the development of libraries of natural products and chemicals; chemical analysis; research services relating to the development of new drugs; provision or lending of microbials, plant extracts and chemical samples | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Xenova LTD.
- Other trademarks owned by TERRAGEN DISCOVERY INC.
- Other trademarks owned by TERRAGEN DISCOVERY INC.
- Other trademarks owned by CUBIST PHARMACEUTICALS, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NATCHEM
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 12, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 24, 2002 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 3, 2002 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 3, 2002 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 23, 2002 | PAPER RECEIVED | — | |
| Apr 24, 2002 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 17, 2002 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 16, 2002 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2001 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 11, 2001 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 17, 2001 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 23, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 22, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 19, 2000 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2000 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Mar 23, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Dec 21, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 1999 | DOCK | ASSIGNED TO EXAMINER | — |